New: NCI-funded clinical trial search
Mednet Logo

Do you start a GLP-1 receptor agonist to reduce decompensation risk in an older adult with MASLD and compensated cirrhosis?

Koutouratsas et al., PMID 42765724
1 Answer
Mednet MemberInvited Expert
Hepatology · Mayo Clinic
Answered on

If they have an approved indication and can get coverage, I would. Need to follow a bit more closely to ensure not rapid weight loss and protein focused with resistance exercise to avoid worse lean mass loss.

Join for free or sign in to see the full answer